최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.31 no.3, 2021년, pp.171 - 179
신호철 (중앙대학교 제약산업학과) , 박재홍 (중앙대학교 제약산업학과) , 김지원 (중앙대학교 제약산업학과) , 백다정 (중앙대학교 제약산업학과) , 이윤지 (중앙대학교 약학대학) , 정선영 (중앙대학교 제약산업학과) , 강원구 (중앙대학교 약학대학) , 김하형 (중앙대학교 약학대학) , 최영욱 (중앙대학교 제약산업학과) , 김은영 (중앙대학교 제약산업학과)
Background: Need for regulatory science is emerging with the development of pharmaceutical industry. It is essential to train regulatory science experts to meet the needs of technology and regulations to evaluate advanced products. Major regulatory science countries are conducting the regulatory sci...
Hines PA, Guy RH, Humphreys AJ, Papaluca-Amati M. The European Medicines Agency's goals for regulatory science to 2025. Nat Rev Drug Discov 2019;18(6):403-4.
Sakuma I. Education and training in regulatory science for medical device development. Annu Int Conf IEEE Eng Med Biol Soc 2013:3155-8.
Hines PA, Guy RH, Brand A, Humphreys AJ, Papaluca-Amati M. Regulatory science and innovation programme for Europe (ReScIPE): A proposed model. Br J Clin Pharmacol 2020;86(12):2530-4.
Honig P, Zhang L. Regulation and innovation: Role of regulatory science in facilitating pharmaceutical innovation. Clin Pharmacol Ther 2019;105(4):778-81.
Donnelly F. Regulatory science as a means to respond to EU healthcare challenges and global market meeds. Journal of Regulatory Science. 2016;4:21-8.
Institute of Medicine. Strengthening a workforce for innovative regulatory science in therapeutics development: workshop summary. Washington (DC): National Academies Press, 2012:31-41.
Meyer RJ. The role of academic medical centers in advancing regulatory science. Clin Pharmacol Ther 2014;95(5):471-3.
Duke-NUS medical school. Center of regulatory excellence. Available from https://www.duke-nus.edu.sg/core. Accessed September 9, 2021.
European Medicines Agency. Road map to 2015. Available from https://www.ema.europa.eu/en/documents/report/road-map-2015-european-medicines-agencys-contribution-science-medicineshealth_en.pdf2010. Accessed September 9, 2021.
Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ-M, Linden HH, et al. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Eur J Pharm Sci 2012;47(5):979-87.
Horizon 2020. Nat Mater. 2012;11(6):477.
Laverty H, Meulien P. The innovative medicines initiative -10 years of public-private collaboration. Front Med (Lausanne) 2019;6:275.
European Medicines Agency. EMA regualtory science to 2025 strategic reflection. Available from https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatoryscience-2025-strategic-reflection_en.pdf. Accessed September 9, 2021.
Goldman M, Wittelsberger A, De Magistris MT. The innovative medicines initiative moves translational immunology forward. Eur J Immunol 2013;43(2):298-302.
Goldman M. The innovative medicines initiative: a European response to the innovation challenge. Clin Pharmacol Ther 2012;91(3):418-25.
Goldman M, Seigneuret N, Eichler HG. The innovative medicines initiative: an engine for regulatory science. Nat Rev Drug Discov 2015;14(1):1-2.
Spindler P, Bach KF, Schmiegelow M, Bedlington N, Eichler HG. Innovation of medical products: The evolution of regulatory science, research, and education. Ther Innov Regul Sci 2016;50(1):44-8.
Innovative Medicines Initiative website. Available from https://www.imi.europa.eu/. Accessed September 9, 2021.
Dance A. Regulatory science: Researchers in the pipeline. Nature 2013;496(7445):387-9.
Innovative Medicines Initiative. Report from the IMI-EMA-FDA regulatory science summit-collaborative research through publicprivate partnership in support to advancing regulatory science. Available from https://www.imi.europa.eu/sites/default/files/uploads/documents/reference-documents/RegulatorySummit2019_report.pdf Accessed September 9, 2021.
Payton A, Janko C, Renn O, Hardman M; EMTRAIN Consortium. On-course( ® ) portal: a tool for in-service training and career development for biomedical scientists. Drug Discov Today 2013; 18(17-18):803-6.
IMI EMTRAIN website. Available from https://www.imi.europa.eu/projects-results/project-factsheets-/emtrain. Accessed September 9, 2021.
Payton A, Dallakian P, Fitton A, Payton A, Hardman M, Yuille M. Course fees and academic ranking: insights from the IMI EMTRAIN on-course ® database. Drug Discov Today 2014;19(7):830-3.
Hardman M, Brooksbank C, Johnson C, et al. LifeTrain: towards a European framework for continuing professional development in biomedical sciences. Nat Rev Drug Discov 2013;12(6):407-8.
LifeTrain website. Available from https://www.lifetrain.eu/. Accessed September 9, 2021.
Klech H, Brooksbank C, Price S, et al. European initiative towards quality standards in education and training for discovery, development and use of medicines. Eur J Pharm Sci 2012;45(5):515-20.
SafeSciMET website. Available from https://ssm.afww.unikonstanz.de/. Accessed September 9, 2021.
Eu2P website. Available from https://eu2p.org/. Accessed September 9, 2021.
Boeynaems JM, Canivet C, Chan A, et al. A European approach to clinical investigator training. Front Pharmacol 2013;4:112.
PharmaTrain website. Available from https://pharmatrain.eu/. Accesssed September 9, 2021.
Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists. Front Pharmacol 2013;4:105.
Kerpel-Fronius S, Rosenkranz B, Allen E, et al. Education and training for medicines development, regulation, and clinical research in emerging countries. Front Pharmacol 2015;6:80.
Silva H, Buhler F, Maillet B, et al. Continuing medical education and professional development in the European Union. Pharm Med 2012;26(4):223-33.
Bongiovanni S, Purdue R, Kornienko O, Bernard R. Quality in non-GXP research environment. In: Bespalov A, Michel M, Steckler T eds. Good research practice in non-clinical pharmacology and biomedicine. Handbook of Experimental Pharmacology, Cham: Springer Open, vol 257, 2020:1-17. https://doi.org/10.1007/164_2019_274. Accessed September 9, 2021
EQIPD website. Available from https://quality-preclinical-data.eu/. Accessed September 9, 2021.
Bespalov A, Bernard R, Gilis A, et al. Introduction to the EQIPD quality system. Elife. 2021;10:e63294.
Ministry of Food and Drug Safety. Regulatory science talent training project (R&D) announcement. 2021. Available from https://www.mfds.go.kr/brd/m_99/view.do?seq44172. Accessed September 9, 2021
※ AI-Helper는 부적절한 답변을 할 수 있습니다.